MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1

MiR-142-3p has been reported to act as a tumor suppressor in breast cancer. However, the regulatory effect of miR-142-3p on drug resistance of breast cancer cells and its underlying mechanism remain unknown. Here, we found that miR-142-3p was significantly downregulated in the doxorubicin (DOX)-resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Lu, Fu, Jijun, Wang, Siran, Cen, Huiyu, Zhang, Lingmin, Mandukhail, Safur Rehman, Du, Lingran, Wu, Qianni, Zhang, Peiquan, Yu, Xiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332808/
https://www.ncbi.nlm.nih.gov/pubmed/32642410
http://dx.doi.org/10.1016/j.apsb.2019.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332808/
https://www.ncbi.nlm.nih.gov/pubmed/32642410
http://dx.doi.org/10.1016/j.apsb.2019.11.009

Ejemplares similares